About La Jolla Labs
La Jolla Labs is a company based in La Jolla (United States) founded in 2020 by Jeff Milton.. La Jolla Labs has raised $3.5 million across 1 funding round. La Jolla Labs offers products and services including RNA-Targeting Discovery Platform, LJSplice, and Screening Technology. La Jolla Labs operates in a competitive market with competitors including Ceretype, Pangea Botanica, cfdx, WM Therapeutics and Dandelion Science, among others.
- Headquarter La Jolla, United States
- Founders Jeff Milton
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name La Jolla Labs Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$3.5 M (USD)
in 1 rounds
-
Latest Funding Round
$3.5 M (USD), Series A
Oct 13, 2021
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of La Jolla Labs
La Jolla Labs offers a comprehensive portfolio of products and services, including RNA-Targeting Discovery Platform, LJSplice, and Screening Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for predicting oligonucleotide therapeutics using machine learning.
Tool for designing efficient RNA splicing strategies on any gene.
Automated high-throughput screening of ASO therapeutics for potency.
Unlock access to complete
Unlock access to complete
Funding Insights of La Jolla Labs
La Jolla Labs has successfully raised a total of $3.5M through 1 strategic funding round. The most recent funding activity was a Series A round of $3.5 million completed in October 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $3.5M
-
First Round
First Round
(13 Oct 2021)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2021 | Amount | Series A - La Jolla Labs | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by La Jolla Labs
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - La Jolla Labs
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
La Jolla Labs Comparisons
Competitors of La Jolla Labs
La Jolla Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ceretype, Pangea Botanica, cfdx, WM Therapeutics and Dandelion Science, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-based brain biomarker technology to improve drug discovery and patient care
|
|
| domain | founded_year | HQ Location |
AI-driven drug discovery for CNS disorders using natural compounds.
|
|
| domain | founded_year | HQ Location |
Neuroscience platform for neurogeneration research and diagnostics is provided.
|
|
| domain | founded_year | HQ Location |
Small-molecule cancer therapeutics are developed to inhibit Warburg metabolism.
|
|
| domain | founded_year | HQ Location |
Therapeutics for brain health are developed via a programmable platform.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about La Jolla Labs
When was La Jolla Labs founded?
La Jolla Labs was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Where is La Jolla Labs located?
La Jolla Labs is headquartered in La Jolla, United States. It is registered at La Jolla, California, United States.
Who is the current CEO of La Jolla Labs?
Jeff Milton is the current CEO of La Jolla Labs. They have also founded this company.
Is La Jolla Labs a funded company?
La Jolla Labs is a funded company, having raised a total of $3.5M across 1 funding round to date. The company's 1st funding round was a Series A of $3.5M, raised on Oct 13, 2021.
What does La Jolla Labs do?
La Jolla Labs was established in 2020 in La Jolla, United States, within the biotechnology sector. An AI-powered discovery platform is operated to advance RNA therapeutics. RNA biology, automation, cloud computing, and machine learning are integrated for high-throughput screening. Focus is placed on rare diseases, with operations supporting therapeutic development for patient treatment.
Who are the top competitors of La Jolla Labs?
La Jolla Labs's top competitors include Pangea Bio, Ceretype and cfdx.
What products or services does La Jolla Labs offer?
La Jolla Labs offers RNA-Targeting Discovery Platform, LJSplice, and Screening Technology.